These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21666596)

  • 1. [Idebenone (noben) -- from theory to practice].
    Rachin AP; Averchenkova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):81-4. PubMed ID: 21666596
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of idebenone.
    Becker C; Bray-French K; Drewe J
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1437-44. PubMed ID: 20955109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction. Idebenone in the treatment of Friedreich ataxia.
    Pandolfo M
    J Neurol; 2009 Mar; 256 Suppl 1():1-2. PubMed ID: 19283343
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of noben (idebenone) in the complex treatment of episodic and chronic migraine].
    Koreshkina MI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):98-101. PubMed ID: 20726168
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effects of coenzyme Q10 in neurodegenerative diseases.
    Beal MF
    Methods Enzymol; 2004; 382():473-87. PubMed ID: 15047118
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of idebenone (noben) in neurological practice].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(11):66-71. PubMed ID: 17176607
    [No Abstract]   [Full Text] [Related]  

  • 7. Coenzyme Q10 in neurodegenerative diseases.
    Shults CW
    Curr Med Chem; 2003 Oct; 10(19):1917-21. PubMed ID: 12871093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases.
    Goldschmidt R; Arce PM; Khdour OM; Collin VC; Dey S; Jaruvangsanti J; Fash DM; Hecht SM
    Bioorg Med Chem; 2013 Feb; 21(4):969-78. PubMed ID: 23313093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
    Parkinson MH; Schulz JB; Giunti P
    J Neurochem; 2013 Aug; 126 Suppl 1():125-41. PubMed ID: 23859348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the pathophysiology of neurodegenerative disorders.
    Willner C
    Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272
    [No Abstract]   [Full Text] [Related]  

  • 11. How can we target oxidative stress in the treatment of neurodegenerative diseases?
    Akasaka H; Ruan KH
    Future Med Chem; 2016 May; 8(8):835-9. PubMed ID: 27173453
    [No Abstract]   [Full Text] [Related]  

  • 12. Coenzyme Q10.
    Pepping J
    Am J Health Syst Pharm; 1999 Mar; 56(6):519-21. PubMed ID: 10192685
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic antioxidants for neurodegenerative disease.
    Linseman DA
    Recent Pat CNS Drug Discov; 2012 Dec; 7(3):183. PubMed ID: 22857712
    [No Abstract]   [Full Text] [Related]  

  • 14. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics.
    Bhagavan HN; Chopra RK
    Free Radic Res; 2006 May; 40(5):445-53. PubMed ID: 16551570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach.
    Abdel-Daim MM; El-Tawil OS; Bungau SG; Atanasov AG
    Oxid Med Cell Longev; 2019; 2019():4179676. PubMed ID: 31467632
    [No Abstract]   [Full Text] [Related]  

  • 16. The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.
    Danta CC; Piplani P
    Expert Opin Drug Discov; 2014 Oct; 9(10):1205-22. PubMed ID: 25056182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Noben (idebenone) in the treatment of dementia and memory impairment without dementia].
    Voronkova KV; Meleshkov MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(4):27-32. PubMed ID: 18454094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease.
    Ghosh N; Ghosh R; Mandal SC
    Free Radic Res; 2011 Aug; 45(8):888-905. PubMed ID: 21615270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio.
    Kernt M; Arend N; Buerger A; Mann T; Haritoglou C; Ulbig MW; Kampik A; Hirneiss C
    J Glaucoma; 2013; 22(5):404-12. PubMed ID: 23661043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emotional disorders and quality of life in patients with post stroke asthenia].
    Boĭko AN; Lebedeva AV; Shchukin IA; Soldatov MA; Petrov SV; Khozova AA; Ismailov AM; Shikhkerimov RK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):27-33. PubMed ID: 24429945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.